Delivery Order SPE2DE24D0013-SPE2D626F156V

The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $23,120 to Cepheid Inc. on November 13, 2025, with an ultimate completion date of November 20, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus. The work will be performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation, reflecting Cepheid's established competitive positioning as a primary federal supplier of advanced molecular diagnostic systems and associated testing solutions. The contract is structured as a firm fixed-price delivery order, consistent with DLA's standard procurement practices for medical supply chain commodities.

Cepheid has emerged as a critical federal partner in diagnostic testing capabilities, serving multiple healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company holds substantial indefinite delivery contracts with the VA, including a $32.8 million agreement with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 through December 2029, which establish the framework for ongoing procurement of GeneXpert diagnostic platform reagents and test kits. This current DLA delivery order represents routine demand-driven procurement of respiratory pathogen testing supplies that support federal healthcare operations and rapid diagnostic capabilities across the military health system and civilian federal medical facilities.